Personalis Inc (NASDAQ:PSNL)
| 3.40 Delayed Data As of 3:59pm ET |  -0.06 / -1.73%Today’s Change | 3.13 Today|||52-Week Range 26.38 | -76.17% Year-to-Date |
Latest PSNL News | Press Releases
No recent news for Personalis Inc.
Today’s Trading
| Previous close | 3.46 |
| Today’s open | 3.51 |
| Day’s range | 3.31 - 3.57 |
| Volume | 42,642 |
| Average volume (3 months) | 585,409 |
| Market cap | $182.7M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -40.79% |
| Earnings growth (this year) | -57.70% |
| Earnings growth (next 5 years) | -16.17% |
| Revenue growth (last year) | +8.70% |
| P/E ratio | NM |
| Price/Sales | 7.33 |
| Price/Book | 0.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JNCEJounce Therapeutics ... | -0.02 | -0.66% |
| DTILPrecision BioScience... | -0.04 | -2.84% |
| CRMDCorMedix Inc | -0.15 | -3.74% |
| INMBINmune Bio Inc | 0.00 | 0.00% |
Data as of 3:59pm ET, 07/01/2022
Financials
| Next reporting date | August 16, 2022 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $85.5M |
| Annual profit (last year) | -$65.2M |
| Net profit margin | -76.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Menlo Park, California |
Forecasts
